cyclo(Gly-Leu),
cyclo(glycylleucyl),
cyclo(Leu-Gly),
cyclo(leucylglycine),
cyclo(leucylglycine), (S)-isomer,
5845-67-0,
(S)-3-ISOBUTYLPIPERAZINE-2,5-DIONE,
MORPHINE TOLERANCE PEPTIDE,
Cyclo(L-leucylglycyl),
Cyclo(leu-gly),
Cyclo(gly-L-leu),
CCRIS 2595,
Cyclo(gly-leu),
(3S)-3-(2-methylpropyl)piperazine-2,5-dione,
Cyclo(glycyl-L-leucyl),
Cyclo(L-Leu-Gly-),
AC1LIAJS,
cyclo(L-leucyl-glycyl),
CYCLO(-LEU-GLY),
Cyclo-(glycyl-l-leucyl),
Cyclo(-Leu-Gly), AldrichCPR,
SCHEMBL2863781,
CHEMBL1957400,
VQFHWKRNHGHZTK-LURJTMIESA-N,
ZINC517578,
3-Isobutyl-2,5-piperazinedione #,
FCH839143,
KM0199,
MFCD00076706,
AKOS006272409,
AB02907,
AK162629,
ZB014264,
AX8122564,
FT-0694640,
ST24036146,
Z5924,
C-54759,
cycloleucylglycine,
CYCLO,
C8H14N2O2,
CID927723,
CYCLO(-LEU-GLY)Cyclo(-Gly-Leu),
ACN-026535,
2,5-Piperazinedione, 3-(2-methylpropyl)-, (3S)-,